Tag: smart insulin pens market demand

  • 2024 Smart Insulin Pens Market Analysis: Market Size, Key Drivers, and Segment Insights

    2024 Smart Insulin Pens Market Analysis: Market Size, Key Drivers, and Segment Insights

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What Will Be the Growth Trajectory of the Smart Insulin Pens Market from 2024 to 2033?

    In the past few years, the market size for smart insulin pens has significantly expanded. It’s projected to grow from $0.1 billion in 2023 to $0.1 billion in 2024, with a compound annual growth rate (CAGR) of 6.0%. The expansion seen in the previous period is owed to the rising number of diabetes cases, solid economic progress in the developing markets, a growing population of elderly individuals, an increase in healthcare spending, and reforms in public health insurance.

    The market for smart insulin pens is predicted to experience significant expansion in the upcoming years, reaching a value of $0.13 billion in 2028 with a compound annual growth rate (CAGR) of 6.4%. The forecasted growth during this period can be linked to the rising disease burden, governmental influence and technological advancements. Noteworthy trends anticipated during this forecast period encompass partnerships with technology entities, intelligent insulin delivery devices, emerging methods of insulin delivery, the integration of the internet of things, and a rise in mergers and acquisitions.

    Claim Your Free Sample of the Global Smart Insulin Pens Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3090&type=smp

    What Are the Primary Growth Drivers for the smart insulin pens Market?

    An insulin pen provides a more accurate dose of insulin than a vial or syringe, making it particularly useful for children needing insulin during school and visually impaired diabetic patients. Accuracy in dose delivery is ensured by the pre-set dosage dial. Novo Nordisk’s Echo Plus, a pediatric-friendly insulin pen, allows dosing in half-units up to a maximum of 30 units. Lilly’s HumaPen Luxura HD and Novo Nordisk’s NovoPen Junior – Insulin Pen deliver insulin in half-unit increments, ensuring high accuracy even for small doses. The ability to avoid under-dosing or over-dosing of the medicine through correct adjustment and delivery is expected to increase smart insulin pens’ demand, fuelling the growth of the smart insulin pens market.

    What Are the Defining Segments of the Smart Insulin Pens Market?

    1) By Type: First Generation Pens, Second Generation Pens

    2) By Usability: Prefilled, Reusable

    3) By Application: Type 1 Diabetes, Type 2 Diabetes

    4) By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings

    What Trends Are Revolutionizing Standards in the Smart Insulin Pens Market?

    The upcoming generation of advanced insulin pens offer more than simple memory storage. They assist in determining personalized dosage, constantly monitoring glucose levels and syncing with smartphone applications to display data. In France, during April 2021, Biocorp and Roche Diabetes Care France initiated the release of the Mallya smart insulin pen device. This device is engineered to improve the day-to-day regimen of individuals with diabetes by recording and retaining crucial treatment details such as insulin unit counts, dates and times of injections. This data, after being gathered, is effortlessly relayed to a specialized mobile application, providing both patients and healthcare workers easy access for real-time supervision and management.

    Order Now for Fast Delivery of Your Smart Insulin Pens Market Report!

    https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

    What Regions Are Propelling Growth in the Smart Insulin Pens Industry?

    North America was the largest region in the smart insulin pens market in 2023. Western Europe was the second largest region in the global smart insulin pens market share. The regions covered in the smart insulin pens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Smart Insulin Pens Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the smart insulin pens market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Smart Insulin Pens Market Include

    1. Smart Insulin Pens Market Executive Summary

    2. Smart Insulin Pens Market Segments

    3. Smart Insulin Pens Market Size And Template Market Growth Rate

    4. Key Smart Insulin Pens Market Trends

    5. Major Smart Insulin Pens Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Smart Insulin Pens Market

    26. Top Smart Insulin Pens Companies

    27. Smart Insulin Pens Market Opportunities And Strategies

    28. Smart Insulin Pens Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Biosimilars Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/biosimilar-global-market-report

    Insulin Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

    Implantable Infusion Pumps Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Smart Insulin Pens Market Analysis: Estimated Market Size And Growth Rate

    Global Smart Insulin Pens Market Analysis: Estimated Market Size And Growth Rate

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    • Accurate Dosing: Insulin pens provide more precise doses compared to vials or syringes.
    • Pediatric and Visually Impaired Patients: Smart insulin pens like Echo Plus and HumaPen Luxura HD offer half-unit dosing, aiding accurate delivery.
    • Market Growth Drivers: Increased demand for precise insulin doses to avoid over or under-dosing.
    • Market Players: Leading companies include Novo Nordisk, F. Hoffmann-La Roche AG, and others.

    Innovative Smart Insulin Pens Enhance The User Experience

    • User-Friendly Design: Companies focus on user-friendly pens like NovoPen 6 and NovoPen Echo Plus.
    • Recording Insulin Dosing: Pens automatically record dosing information and can transfer it to apps.
    • Novo Nordisk’s Initiatives: Launch of smart insulin pens, enabling data sharing with healthcare providers.

    View More On The Smart Insulin Pens Market Report 2024 – https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

    Novo Nordisk Strengthens Medical Device Portfolio Through Acquisition Of Biocorp

    • Acquisition Details: Novo Nordisk acquires Biocorp for $164.5 million in October 2023.
    • Accelerating Device Development: Biocorp’s expertise enhances Novo Nordisk’s device development.
    • Market Segmentation: Segments include type, usability, application, and end-user.
    • Regional Dominance: North America led the smart insulin pens market in 2023.

    The smart insulin pens market has witnessed substantial growth in recent years, with projections indicating continued expansion in the coming years. The following insights shed light on the market dynamics and key players shaping this growth trajectory.

    Accurate Dosing for Enhanced Care

    Insulin pens offer a more accurate dose delivery compared to traditional methods like vials and syringes. This precision is particularly beneficial for populations such as children who require insulin during school hours and visually impaired patients. Smart insulin pens like Echo Plus and HumaPen Luxura HD enable half-unit dosing, ensuring precise delivery and reducing the risk of under or over-dosing. Consequently, the demand for smart insulin pens is expected to surge, driving market growth.

    Innovation Driving User Experience

    Companies are prioritizing user-friendly designs to enhance the insulin delivery experience. NovoPen 6 and NovoPen Echo Plus exemplify this trend, incorporating features that simplify dosing and record-keeping. These pens automatically capture dosing information, which can be conveniently transferred to compatible apps for monitoring and sharing with healthcare providers. Such innovations not only improve patient experience but also contribute to market expansion.

    Strategic Acquisitions and Market Expansion

    In a strategic move to bolster its medical device portfolio, Novo Nordisk acquired Biocorp, a prominent player in the medical device sector. This acquisition is poised to accelerate Novo Nordisk’s device development initiatives, fostering innovation and market penetration. Furthermore, market segmentation based on type, usability, application, and end-user provides valuable insights into consumer preferences and market trends.

    Regional Trends and Market Leadership

    North America emerged as the leading region in the smart insulin pens market in 2023, underscoring its significance in driving market dynamics. Factors such as increasing diabetes prevalence, technological advancements, and favorable regulatory frameworks contribute to the region’s dominance. However, with growing awareness and adoption of smart insulin pens globally, other regions are also expected to witness substantial growth opportunities.

    In conclusion, the smart insulin pens market presents lucrative prospects fueled by technological advancements, strategic collaborations, and increasing healthcare needs. With continued innovation and market expansion efforts, key players are poised to capitalize on these opportunities, ultimately enhancing diabetes care and improving patient outcomes.

    Request A Sample Of The Global Smart Insulin Pens Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=3090&type=smp